Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Reneo Pharmaceuticals Inc (NQ: RPHM )

1.750 +0.090 (+5.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 204,823
Open 1.610
Bid (Size) 1.690 (3)
Ask (Size) 1.740 (10)
Prev. Close 1.660
Today's Range 1.610 - 1.760
52wk Range 0.9801 - 9.450
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Reneo Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga

Performance

YTD
+5.42%
+5.42%
1 Month
-1.13%
-1.13%
3 Month
+6.06%
+6.06%
6 Month
-74.11%
-74.11%
1 Year
-77.24%
-77.24%

More News

Read More
RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM
From Kahn Swick & Foti, LLC
Via Business Wire
What's Going On With Reneo Pharmaceuticals Stock Today?
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reneo Pharmaceuticals, Inc. (Nasdaq – RPHM), ALLETE, Inc. (NYSE – ALE), Perficient, Inc. (Nasdaq – PRFT), Hibbett, Inc. (Nasdaq – HIBB)
From Brodsky & Smith LLC
Via GlobeNewswire
RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
From Reneo Pharmaceuticals, Inc.; OnKure, Inc
Via GlobeNewswire
RPHM Stock Earnings: Reneo Pharmaceuticals Beats EPS for Q1 2024
Via InvestorPlace
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Reneo Pharmaceuticals: Q4 Earnings Insights
Via Benzinga
5 Analysts Have This to Say About Reneo Pharmaceuticals
Via Benzinga
Recap: Reneo Pharmaceuticals Q3 Earnings
Via Benzinga
RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q4 2023
Via InvestorPlace
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
From Sagimet Biosciences Inc.
Via GlobeNewswire
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nasdaq Turns Lower; US Retail Sales Top Estimates
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Is Genetic Disease Focused Reneo Pharmaceuticals Stock Plummeting Today?
Via Benzinga
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings
From Reneo Pharmaceuticals, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.